7MMB
Crystal structure of HCV NS3/4A D168A protease in complex with NR01-127
Summary for 7MMB
Entry DOI | 10.2210/pdb7mmb/pdb |
Descriptor | NS3 protease, cyclobutyl {(2R,4S,6S,12Z,13aS,14aR,16aS)-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-14a-[(1-methylcyclopropane-1-sulfonyl)carbamoyl]-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-6-yl}carbamate, 1,2-ETHANEDIOL, ... (6 entities in total) |
Functional Keywords | ns3/4a protease, hepatitis c virus, drug resistance, protease inhibitor, hydrolase-hydrolase inhibitor complex, hydrolase, hydrolase-inhibitor complex, viral protein, hydrolase/inhibitor |
Biological source | Hepacivirus C |
Total number of polymer chains | 1 |
Total formula weight | 22528.70 |
Authors | Zephyr, J.,Schiffer, C.A. (deposition date: 2021-04-29, release date: 2022-03-16, Last modification date: 2023-10-18) |
Primary citation | Zephyr, J.,Nageswara Rao, D.,Vo, S.V.,Henes, M.,Kosovrasti, K.,Matthew, A.N.,Hedger, A.K.,Timm, J.,Chan, E.T.,Ali, A.,Kurt Yilmaz, N.,Schiffer, C.A. Deciphering the Molecular Mechanism of HCV Protease Inhibitor Fluorination as a General Approach to Avoid Drug Resistance. J.Mol.Biol., 434:167503-167503, 2022 Cited by PubMed: 35183560DOI: 10.1016/j.jmb.2022.167503 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.99 Å) |
Structure validation
Download full validation report